Page 2 - Sample Services News Today

The Government of Victoria in Australia has broken ground on the new $105.4m (A$152m) worth melanoma and clinical trials centre.

F. Hoffmann-La Roche’s IT hiring rises 65.3% in April 2022 when compared with the previous month, according to GlobalData’s Job Analytics

There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers develop reliable antivirals and vaccines?

Humanetics has expanded clinical trial of a new oral drug, BIO 300, for long-haul Covid-19 (long COVID) to include two more US study sites.

Skye Bioscience has retained CMAX clinical Research for Phase I trial of its SBI-100 OE being developed for potential treatment of glaucoma.

Alterity Therapeutics has received the MHRA acceptance for its request to proceed with Phase II trial of ATH434 in MSA.

Priothera has announced plans to commence Phase IIb/III trial of mocravimod in acute myeloid leukaemia patients undergoing allogeneic HSCT.

Shionogi has reported data from two trials of Covid-19 antiviral, S-217622, that concluded in Asia demonstrated rapid clearance of the virus.

Clinical Trials Arena looks at a potential shake-up in alopecia areata's treatment paradigm and an emerging treatment mechanism.

Sorrento Therapeutics has obtained the US FDA clearance to initiate the Phase II/III trial of Abivertinib in hospitalised Covid-19 patients.